Study of galantamine as treatment for emotional problems of autism
The EVMS Autism Spectrum Disorder Program is conducting a clinical research trial of a potential medication for emotion regulation, information processing and flexibility of thought in ASD with all cognitive levels. Study participants must be 12-25 years old with a pre-established diagnosis of ASD. Participants must be generally healthy. The study will last for approximately four months and require five visits to EVMS lasting one to two hours each. Parking will be paid and participants may receive a small reimbursement for their time. For additional information, call 757.446.5176.